about
Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas.Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.Ultra-short bowel is an independent risk factor for liver fibrosis in adults with home parenteral nutrition.Testing feasibility of an accurate microscopic assessment of macrovesicular steatosis in liver allograft biopsies by smartphone add-on lenses.Contribution of virtual biopsy to the screening of microvascular invasion in hepatocellular carcinoma: A pilot study.A gastric MANEC with an adenocarcinoma of fundic-gland type as exocrine component.Liver transplantation in adult cystic fibrosis: Clinical, imaging, and pathological evidence of obliterative portal venopathy.Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.Noninvasive assessment of liver steatosis in deceased donors: A pilot study.Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas.Small bowel adenocarcinoma complicating Crohn's disease: a single-centre experience emphasizing the importance of screening for dysplasia.Distal intramural and tumor spread in the mesorectum after neoadjuvant radiochemotherapy in rectal cancer: about 124 consecutive patients.Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasionSomatostatin Receptor Subtype 2 Expression and Somatostatin Receptor Scintigraphy Positivity in Pancreatic Serous CystadenomasTumor Heterogeneity in Pancreatic Adenocarcinoma.Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway InactivationThe histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma
P50
Q34647317-486B3418-F9BE-44D4-82C1-92382C9A291BQ36716630-8027CE9C-DE1A-4824-B75E-AC8FCA2D1618Q39190497-B874D529-8C11-40A7-99A4-3B7ECDBEE30EQ47433347-1500FDA1-F7F9-44B1-9590-C2AB501B5940Q47964964-9B9DF7D8-D49A-4B03-A2AA-0F9A13C03B41Q48219548-2BE02B3B-E57C-49BB-B639-B42831F2CF78Q48224685-7049BF0E-1662-438E-9C13-737C07F16873Q48341630-9B831D43-F691-4B35-B9F6-8DC58B89FAC6Q48356132-5350C60D-A813-490F-A149-3E313CC080C3Q50959212-DCF619C0-0152-4922-9E55-D7D2D0297918Q52879611-99C6D66C-1CA9-44BD-B6D7-B2CAF1EA524EQ53094843-69832267-8FFF-4563-AEDA-EFDA737A849FQ57782438-2635B69B-FF71-4649-A69E-1D27ADCE65CAQ57782670-B2FFF14E-B1E9-4257-9605-7383203699ECQ64962249-4AA2E8AE-6CA7-44DD-8347-AB22E745E07AQ84850053-619DEE1D-09D5-42A6-9E6A-0F1A8B54F40AQ88763334-F64AB944-71FD-4576-97A2-F08338071295Q92679884-262DD9D3-D55B-461C-B29B-0FC252F8E36F
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7695-7317
@en
name
Nicolas Poté
@ast
Nicolas Poté
@en
Nicolas Poté
@nl
type
label
Nicolas Poté
@ast
Nicolas Poté
@en
Nicolas Poté
@nl
prefLabel
Nicolas Poté
@ast
Nicolas Poté
@en
Nicolas Poté
@nl
P106
P21
P31
P496
0000-0001-7695-7317